Publications by authors named "Simone Naruhn"

Claim this Profile
(
(Z)-2-(2-bromophenyl)-3-{[4-(1-methyl-piperazine)amino]phenyl}acrylonitrile (DG172): an orally bioavailable PPARβ/δ-selective ligand with inverse agonistic properties.
Sonja Lieber, Frithjof Scheer, Wolfgang Meissner, Simone Naruhn, Till Adhikary

J Med Chem· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of improved PPARβ/δ inhibitors.
Philipp M Toth, Simone Naruhn, Veronika F S Pape, Stefanie M A Dörr, Gerhard Klebe

ChemMedChem· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-affinity peroxisome proliferator-activated receptor β/δ-specific ligands with pure antagonistic or inverse agonistic properties.
Simone Naruhn, Philipp M Toth, Till Adhikary, Kerstin Kaddatz, Veronika Pape

Mol Pharmacol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular and pharmacological selectivity of the peroxisome proliferator-activated receptor-beta/delta antagonist GSK3787.
Prajakta S Palkar, Michael G Borland, Simone Naruhn, Christina H Ferry, Christina Lee

Mol Pharmacol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
15-hydroxyeicosatetraenoic acid is a preferential peroxisome proliferator-activated receptor beta/delta agonist.
Simone Naruhn, Wolfgang Meissner, Till Adhikary, Kerstin Kaddatz, Thomas Klein

Mol Pharmacol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis